Third dose of COVID-19 vaccines being offered to people with severely lowered immunity

The UK is to begin a programme of third COVID-19 vaccine doses for people with severely weakened immune systems. This includes many people affected by lymphoma.

Third jab

We’re pleased that the Joint Committee on Vaccination and Immunisation (JCVI) has recommended a programme of third COVID-19 vaccine doses for people with severely lowered immunity. These people are at higher risk of becoming seriously ill from COVID-19, and might not have responded well to their initial course of vaccination.

Many people with lymphoma will be eligible for third doses.

Who can have a third dose?

A third dose is recommended for people who had severely weakened immune systems at the time they had their initial vaccine doses. This is because they may not have responded to vaccination as well as healthy people.

You do not need to have an antibody test to find out whether or not you responded in order to have a third dose.

Those eligible for a third dose include:

  • People with Hodgkin lymphoma or high-grade non-Hodgkin lymphoma who were on treatment or within 12 months of achieving cure at the time they had their initial COVID-19 vaccinations.
  • People with low-grade non-Hodgkin lymphoma or chronic lymphocytic leukaemia (CLL) who were under follow-up at the time they had their initial COVID-19 vaccinations. This might include some people on active monitoring (watch and wait), if their immune systems are severely weakened. Specialists will consider the individual circumstances to decide whether or not people on active monitoring are likely to need a third dose.
  • People who had a self (autologous) or donor (allogeneic) stem cell transplant in the 2 years before they had their initial COVID-19 vaccinations (or more than 2 years for people who are still immunosuppressed or have graft-versus-host disease). Note that people who had a stem cell transplant or CAR T-cell therapy after their initial COVID-19 vaccinations should be completely revaccinated 3 to 6 months after treatment.
  • People who were on immunosuppressive chemotherapy or radiotherapy at the time of their initial COVID-19 vaccinations or within the previous 6 months.
  • People who had high-dose steroids in the month before their initial COVID-19 vaccinations.

This list does not include all eligible people – we have focused on those that are relevant to people affected by lymphoma. The full JCVI guidance includes a more detailed list of people who are eligible.

As announced earlier in the year, people aged 12 and over who live with someone who has a severely weakened immune system are also eligible for vaccination. They will receive the usual course of two doses.

How do I get a third dose?

GPs and hospital specialists have been asked to check their lists to identify people who are eligible for a third dose. If you are eligible, you should get a letter as soon as possible telling you how to get your vaccination. The letter might come from your hospital specialist or from your GP.

If you think you are eligible for a third dose and you don’t receive a letter in the next few weeks, contact your GP for advice.

When can I have a third dose?

If you are eligible for a third dose, your specialist will consider the best time for you to have it. It should be at least 8 weeks after your second dose.

  • If possible, you should have your third dose at least 2 weeks after your immune system recovers.
  • If this isn’t possible, you should have your third dose during a period when your immune system is least weakened (for example, in between cycles of treatment or during a treatment holiday).
  • If your immune system is always severely weakened, you should still have a third dose. You can have this at any time from 8 weeks after your second dose.
Which vaccine will I get?

Whichever vaccine you had for your first two doses, the JCVI recommends that most eligible adults should have either the Pfizer or Moderna vaccines for their third dose.  The Astra Zeneca vaccine might be used in some cases.

The Pfizer vaccine is recommended for eligible 12-to-17 year olds.

Am I likely to respond to a third dose if I didn’t respond to the first two?

Clinical trials are looking into this at the moment. Early evidence suggests that some people with lowered immunity have an improved immune response after a third dose of COVID-19 vaccination. However, some people still may not respond. It is important to keep taking precautions to reduce your risk of developing COVID-19.

Is this the same as a booster dose?

Not quite. Booster doses aim to help your immune response to vaccination last as long as possible. This programme is called a ‘third primary dose’. It aims to improve the initial response to vaccination in people who may not have responded well to their first two doses.

The government is rolling out a booster programme for older people and those at higher risk of becoming seriously ill from COVID-19. This is not limited to people with lowered immunity. If you are not eligible for a third primary dose, you are likely to be eligible for a booster dose.

People who receive a third primary dose are expected to be eligible for a booster 6 months after their third dose, but we are waiting for confirmation of this.

What if I’m not eligible for a third dose?

If you developed a weakened immune system 2 weeks or more after your initial course of COVID-19 vaccination, you are unlikely to be eligible for a third dose at this stage. However, you are likely to be eligible for a routine booster dose. The NHS will contact you when it is your turn to have a booster.

First published 2 September 2021
Updated 17 September 2021